United States - English - NLM (National Library of Medicine)

meridian animal health - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - benzalkonium chloride 0.13 g in 118 ml - dogmd maximum defensetm hot spot skin remedy is formulated to be effective for skin irritations. specifically kills s taphylococcus intermedius bacteria, which is commonly associated with hot spots on dogs. kills topical bacteria, fungus and viruses. dogmd maximum defensetm hot spot skin remedy is indicated for superficial cuts, scrapes, and abrasions. best of all, it contains no alcohol and is a non-stinging formula. signs of hot spots: hot spots are usually accompanied by incessant rubbing, scratching and biting due to intense itching. other signs are moist, reddened areas, hair loss, and flaky skin. hot spots are usually warm to the touch.

United States - English - NLM (National Library of Medicine)

meridian animal health - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y), benzyl alcohol (unii: lkg8494wbh) (benzyl alcohol - unii:lkg8494wbh) - benzalkonium chloride 0.325 g in 248 g - dogmd maximum defense™ anti-itch spray was developed for aiding the soothing, drying and healing of moist "hot spots." it also relieves itching and helps control the spread of lesions. provides immediate soothing relief. does not sting on application. safe for dogs at least 6 weeks of age. signs: recommended for dogs with small, moist “hot spots.”

United States - English - NLM (National Library of Medicine)

sergeant's pet care products, inc - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - benzalkonium chloride 0.13 g in 118 ml - fast relief. effective. soothing. non-stinging. alcohol-free.  petarmor for dogs hot spot skin remedy kills topical bacteria, fungus and viruses associated with hot spots. remedy for superficial cuts, scrapes, and abrasions. other hot spot signs:  biting and skin flaking.

United States - English - NLM (National Library of Medicine)

united exchange corp. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride 0.05 mg in 100 ml - uses temporarily relieves nasal congestion due to: - common cold - hay fever - upper respiratory allergies - temprarily relievves sinus congestion and pressure - shrinks swollen nasal membranes so you can breathe more freely stop use and ask a doctor if symptoms persist directions - adults and children 6 to 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. do not exceed 2 doses in any 24-hour period. - children under 8 years of age: ask a doctor. shake well before use. to open, rotate cap to align the marks. squeeze cap on both sides in a counter-clockwise turn and pull off to remove. to spray, remove clamp and hold bottle with thumb at base and nozzle between first and second fingers. without tiliting the head, insert nozzle into nostril. fully depress rim with a firm, even stroke and sniff deeply. wipe nozzle clean after use and snap cap back onto the bottle.

United States - English - NLM (National Library of Medicine)

heb - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - benzalkonium chloride 1.3 g in 1 ml - antibacterial for handwashing to decrease bacteria on the skin - irritation or redness develops - condition persists for more than 72 hours

United States - English - NLM (National Library of Medicine)

s.p. richards company - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - benzalkonium chloride 1.3 mg in 1 ml - antiseptic to decrease bacteria on the skin - irritation or redness develops - condition persists for more than 72 hours

United States - English - NLM (National Library of Medicine)

diamond wipes international - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - benzalkonium chloride 0.13 mg in 1 ml - antimicrobial ■ for hand sanitizing to decrease bacteria on skin

United States - English - NLM (National Library of Medicine)

carestream health, inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride anhydrous 20 mg in 1 ml - lidocaine and epinephrine injection, usp solutions are indicated for the production of local anesthesia for dental procedures by nerve block or infiltration techniques. only accepted procedures for these techniques as described in standard textbooks are recommended. lidocaine and epinephrine injection,usp is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to any components of the injectable formulations.

United States - English - NLM (National Library of Medicine)

akorn - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine hydrochloride ophthalmic solution usp, 0.1% is indicated for the treatment of the signs and symptoms of allergic conjunctivitis. olopatadine hydrochloride ophthalmic solution usp, 0.1% is contraindicated in persons with a known hypersensitivity to olopatadine hydrochloride or any components of olopatadine hydrochloride ophthalmic solution usp, 0.1%.

United States - English - NLM (National Library of Medicine)

akorn - epinastine hydrochloride (unii: gfm415s5xl) (epinastine - unii:q13wx941ef) - epinastine hydrochloride ophthalmic solution is indicated for the prevention of itching associated with allergic conjunctivitis. none teratogenic effects pregnancy category c in an embryofetal developmental study in pregnant rats, maternal toxicity with no embryofetal effects was observed at an oral dose that was approximately 150,000 times the maximum recommended ocular human dose (mrohd) of 0.0014 mg/kg/day on a mg/kg basis. total resorptions and abortion were observed in an embryofetal study in pregnant rabbits at an oral dose that was approximately 55,000 times the mrohd. in both studies, no drug-induced teratogenic effects were noted. epinastine reduced pup body weight gain following an oral dose to pregnant rats that was approximately 90,000 times the mrohd. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, epinastine hydrochloride ophthalmic solution should be used during pregnancy only if the